You are here
- Home
- intervention development
intervention development
- F21 Co-design of a lifestyle intervention to improve quality of life in Huntington’s diseaseCheney JG Drew, Kim Munnery, Fiona Wood, Monica BusseJournal of Neurology, Neurosurgery & Psychiatry Sep 2022, 93 (Suppl 1) A43-A44; DOI: 10.1136/jnnp-2022-ehdn.112
- Special collections
- JNNP Internet (21)
- JNNP Patients' choice (130)
- Editor's choice (140)
- Open access (468)
- Press releases (58)
- CLINICAL
- Radiology (1967)
- Rehabilitation medicine
- Disability (218)
- Physiotherapy (73)
- Rheumatology
- Fibromyalgia (8)
- Vascularitis (105)
- Respiratory medicine
- Psychiatry
- Somatoform disorders (70)
- Suicide (psychiatry) (43)
- Sleep disorders (169)
- Psychotherapy (12)
- Psychiatry of old age (429)
- Delirium (49)
- Eating disorders (30)
- Drugs: psychiatry (236)
- Sports and exercise medicine
- Sports
- Sexual health
- Sexual dysfunction (13)
- Surgery
- Urological surgery (20)
- Surgical oncology (161)
- Otolaryngology / ENT (11)
- Neurology
- Brain stem / cerebellum (753)
- Cerebral palsy (15)
- Drugs: CNS (not psychiatric) (2340)
- Epilepsy and seizures (982)
- Dementia (1239)
- Cranial nerves (621)
- Hydrocephalus (153)
- Infection (neurology) (574)
- Trauma CNS / PNS (447)
- Stroke (1708)
- Spinal cord (682)
- Peripheral nerve disease (742)
- Parkinson's disease (876)
- Muscle disease (302)
- Multiple sclerosis (1139)
- Motor neurone disease (415)
- Neuroimaging (442)
- Pain (neurology) (856)
- Neurooncology (265)
- Neurological injury (447)
- Neuromuscular disease (1585)
- Intensive care
- Adult intensive care (57)
- Infectious diseases
- HIV/AIDS (118)
- Cardiovascular medicine
- Hypertension (440)
- Anaesthesia
- Pain (anaesthesia) (38)
- Diagnostics
- Radiology (diagnostics) (1471)
- Gastroenterology
- Oncology
- CNS cancer (209)
- Ophthalmology (971)
- Pharmacology and therapeutics
- Palliative care
- Hospice (39)